Accéder au contenu
Merck

A protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons.

STAR protocols (2023-06-13)
Kaneyasu Nishimura, Emilía Sif Ásgrímsdóttir, Shanzheng Yang, Ernest Arenas
RÉSUMÉ

Here, we present a protocol for the generation of functional midbrain dopaminergic (mDA) neurons from human embryonic stem cells (hESCs), which mimics the development of the human ventral midbrain. We describe steps for hESC proliferation, induction of mDA progenitors, freezing stocks of mDA progenitors as an intermediate starting point to reduce the time to make mDA neurons, and maturation of mDA neurons. The entire protocol is feeder-free and uses chemically defined materials. For complete details on the use and execution of this protocol, please refer to Nishimura et al. (2023).1.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
N6,2′-O-Dibutyryladénosine 3′,5′-monophosphate cyclique sodium salt, ≥96% (HPLC), powder
Sigma-Aldrich
CHIR99021, ≥98% (HPLC)
Sigma-Aldrich
Anticorps anti-tyrosine hydroxylase, Chemicon®, from rabbit
Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
Anticorps anti-Sox2, Chemicon®, from rabbit
Sigma-Aldrich
SU-5402, ≥98% (HPLC)
Sigma-Aldrich
GW3965 hydrochloride, ≥98% (HPLC), powder
Sigma-Aldrich
Anticorps anti-LMX-1, serum, from rabbit